A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.

NCT00432562 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Non-small Cell Lung Cancer
Non-Hodgkins Lymphoma

Interventions

DRUG: Vinorelbine Tartrate

Sponsor

Mast Therapeutics, Inc.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]